Search results
Results from the WOW.Com Content Network
The final amount covered Clean Water Act penalties and environmental damages from the initial explosion, which killed 11 workers and spilled 134 million gallons of oil that spread across 43,000 miles.
New York State Attorney General at New York Foreign Press Center Briefing on 'Issues Facing New York' In addition to prosecutions and civil actions in the financial sector, former Attorney General of New York Eliot Spitzer pursued cases in both state and federal courts involving pollution, entertainment, technology, occupational safety and health and other fields in which New York plays a part ...
The following is a list of the 21 largest civil settlements, reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2017, ordered by the size of the total civil settlement. Some of these matters also resolved criminal fines and penalties, listed in parentheses, but these amounts are not considered when ...
Adult Survivors Act; New York State Legislature; Full name: AN ACT to amend the civil practice law and rules, in relation to the statute of limitations for civil actions related to certain sexual offenses committed against a person eighteen years of age or older, reviving such actions otherwise barred by the existing statute of limitations and granting trial preference to such actions; and to ...
An Illinois woman unsuccessfully sued for $5 million for similar reasons, and at least a couple more lawsuits are pending, according to the New York Post. robtek/istockphoto There’s Too Much Air ...
Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a setback for a company still facing thousands of other opioid-related lawsuits around the ...
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
The law now has been the basis of more than 20,000 class action lawsuits, filed against multiple companies for violating it, the New Jersey Law Journal reported.